ClinVar Miner

Submissions for variant NM_001943.5(DSG2):c.1781T>C (p.Leu594Pro)

gnomAD frequency: 0.00038  dbSNP: rs199681901
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000172530 SCV000050911 likely benign not provided 2013-06-24 criteria provided, single submitter research
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000037272 SCV000060929 uncertain significance not specified 2014-08-27 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The Leu594Pro varia nt in DSG2 has been identified in 4/8470 European American chromosomes by the NH LBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs19968190 1). Our laboratory has previously detected this variant in 3 individuals (1 Asia n child with HCM and WPW, 1 Ashkenazi Jewish adult with possible DCM/ARVC, and 1 Ashkenazi Jewish adult with HCM). Leucine (Leu) at position 594 is not conserve d in mammals or evolutionarily distant species, raising the possibility that a c hange at this position may be tolerated. Additional computational prediction too ls suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clini cal significance of the Leu594Pro variant is uncertain, these data suggest that it is more likely to be benign.
Invitae RCV001085411 SCV000561400 likely benign Arrhythmogenic right ventricular dysplasia 10 2024-02-01 criteria provided, single submitter clinical testing
GeneDx RCV000037272 SCV000714372 likely benign not specified 2018-01-22 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000618191 SCV000735732 likely benign Cardiovascular phenotype 2018-03-07 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Color Diagnostics, LLC DBA Color Health RCV000776195 SCV000911324 benign Cardiomyopathy 2018-08-14 criteria provided, single submitter clinical testing
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego RCV000852742 SCV000995459 likely benign Primary dilated cardiomyopathy 2018-04-06 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001085411 SCV001286958 benign Arrhythmogenic right ventricular dysplasia 10 2018-05-11 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.
CeGaT Center for Human Genetics Tuebingen RCV000172530 SCV002822452 likely benign not provided 2024-02-01 criteria provided, single submitter clinical testing DSG2: BP4
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000776195 SCV003838788 likely benign Cardiomyopathy 2021-08-20 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000037272 SCV004241802 likely benign not specified 2023-12-04 criteria provided, single submitter clinical testing Variant summary: DSG2 c.1781T>C (p.Leu594Pro) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00063 in 249162 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 2.52 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSG2 causing Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy phenotype (0.00025), suggesting that the variant is benign. c.1781T>C has been reported in the literature in a heterozygous individual affected with Brugada syndrome (e.g. DiResta_2015) and in a case of sudden infant death syndrome reported as a VUS (e.g. Neubauer_2017). These report(s) do not provide unequivocal conclusions about association of the variant with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26220970, 21636032, 28074886). Twelve submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, classifying the variant as benign (n=3), likely benign (n=8), or uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as likely benign.
PreventionGenetics, part of Exact Sciences RCV003952429 SCV004768410 likely benign DSG2-related condition 2024-02-13 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Clinical Genetics, Academic Medical Center RCV000037272 SCV001924538 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000172530 SCV001975715 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.